Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); Attractive Entry Point
-
Canaccord Genuity Maintains a 'Hold' on SandRidge Energy (SD); Price Target Cut Cash Flow Outspend and Higher Opex
-
Canaccord Genuity Reiterates a 'Buy' on Pioneer Natural Resources (PXD); Acceleration & Deeper Drilling to Drive Multi-Year Growth
-
UPDATE - Canaccord Genuity Upgraded Bill Barrett (BBG) to Buy; Q2/11: Uinta Basin Oil A Game-Changer
-
Canaccord Genuity Upgrades Bill Barrett (BBG) to Buy
-
Exa Corp. (EXA) Files $86.25M IPO
-
Canaccord Genuity Upgrades U.S. Ecology (ECOL) to Buy
-
Canaccord Genuity Upgrades Trimble Navigation (TRMB) to Buy
-
Canaccord Genuity Reiterates a 'Buy' on Hologic (HOLX); Q3 In-line
-
Canaccord Genuity Maintains a 'Buy' on ZIOPHARM Oncology (ZIOP); Q2/11 Update
-
Canaccord Genuity Maintains a 'Hold' on Volcano Corp. (VOLC); Solid Q2; Patiently Awaiting More Attractive Entry Point
-
Canaccord Genuity Starts TranS1 Inc (TSON) at Buy; Cracking the Code to the $1.5B AxiaLIF Market Opportunity
-
Canaccord Genuity reiterates a 'Buy' on ICF International (ICFI); Revising 2011 EPS Higher, Valuation Remains Compelling
-
Canaccord Genuity Reiterates a 'Buy' on Integrated Device Technology (IDTI); Gross margins resilient in face of slowdown
-
Argos Therapeutics (ARGS) Files $86.25M IPO
-
Canaccord Genuity Maintains a 'Buy' on Elster Group SE (ELT); Gas Continues to Go
-
Canaccord Genuity Maintains a 'Hold' on Rubicon Technology (RBCN); Resetting Expectations on Lower Near-Term Sapphire Pricing
-
Canaccord Genuity Reiterates a 'Buy' on Apple (AAPL); Increases Value Share and Captures Smartphone Market Share
-
Canaccord Genuity Reiterates a 'Buy' on Key Energy Services (KEG); Beat Boosts 2012 Outlook
-
Canaccord Genuity Maintains a 'Hold' on Helmerich & Payne (HP); Mixed Quarter, but New Builds Pushing Numbers Higher
-
Canaccord Genuity Reiterates a 'Buy' on RTI Biologics (RTIX); Beat and Raise in Difficult Market; Spine Outperformed
-
Canaccord Genuity Maintains a 'Hold' on Celgene (CELG); Raising Numbers on Q2 Beat
-
Canaccord Genuity Maintains a 'Hold' on Veeco Instruments (VECO); Slight Miss for Q2; No Change in Cautious View, but Valuation Remains Reasonable
-
Canaccord Genuity Maintains a 'Hold' on Coinstar (CSTR); N-T Upside Balanced Against Deteriorating Macro; No Incremental News on Digital Partnership
-
Canaccord Genuity Maintains a 'Hold' on Motorola Mobility Holdings (MMI); Solid Q2/11, Soft Guidance
-
Canaccord Genuity Reiterates a 'Buy' on SPS Commerce (SPSC); Accelerating Growth as Business Approaches a Tipping Point
-
Canaccord Genuity Maintains a 'Hold' on NetSuite (N); Another Excellent Quarter; We'll Wait and Hope for Temporary Break
-
UPDATE - Canaccord Genuity Downgrades TeleNav (TNAV) to Hold; More Rapid Transition Resets Financial Model
-
Canaccord Genuity Reiterates a 'Buy' on Patterson-UTI Energy (PTEN); Nice Quarter, Outlook Remains Strong
-
Canaccord Genuity reiterates a 'Sell' on EQT Corp. (EQT); Q2/11: Evolving Marcellus Well Design, Valuation the Issue
-
Canaccord Genuity Reiterates a 'Buy/Top Pick' on Cabot Oil & Gas (COG); Q2/11: Simply Outstanding
-
Canaccord Genuity Downgrades TeleNav (TNAV) to Hold
-
Canaccord Genuity Downgrades NetSuite (N) to Hold
-
Canaccord Genuity Lifts Price Target On Green Mountain (GMCR) to $120
-
Canaccord Genuity Reiterates a 'Buy' on Whole Foods Market (WFMI); Healthy Momentum Continues
-
Canaccord Genuity Maintains a 'Buy' on Trius Therapeutics (TSRX); Partnership Validates Torezolid Potential
-
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); IPF Expert Lunch: Thoughts on Pirfenidone Europe Launch
-
Canaccord Genuity Maintains a 'Hold' on Greatbatch (GB); Still Expect Sluggish Growth
-
Canaccord Genuity Reiterates a 'Buy' on Alere (ALR); HM Misses, but Dx Attractive; Lowering Target
-
Canaccord Genuity Reiterates a 'Buy' on Kadant Inc. (KAI); Excellent Q2 Results, 2011 Earnings Outlook Intact
-
Canaccord Genuity Maintains a 'Buy' on Itron (ITRI); In-line Q2; It's Wait & See for Q3
-
Canaccord Genuity Maintains a 'Hold' on Interface (IFSIA); Sales Strength Helps Offset Tighter Margins
-
Canaccord Genuity Maintains a 'Hold' on Shutterfly (SFLY); Combination Shows Strong Q2
-
Canaccord Genuity reiterates a 'Buy' on Intersil (ISIL); Strong Industrial in the Face of Softness for PC and Consumer
-
Canaccord Genuity Reiterates a 'Buy' on Nabors (NBR); After In-line Q2, Stay Patient for 2012
-
Canaccord Genuity Reiterates a 'Hold' on Vertex Pharma (VRTX); Q2 Preview
-
Canaccord Genuity Maintains a 'Hold' on Pentair (PNR); Q2/11 Review
-
Canaccord Genuity Maintains a 'Buy' on Jones Lang LaSalle (JLL); Solid Q2 Results, Real Estate Recovery on Track
-
Canaccord Genuity Reiterates a 'Buy' on GLG Life Tech (GLGC); ANOC Expansion Coming Into Focus;
-
Canaccord Genuity Reiterates a 'Buy' on Ultimate Software (ULTI); Solid Results: In-line Across the Board; Big Implicit Margin Ramp in Q4 Adds Stress
